Relmada Therapeutics (RLMD) Amortizatization of Intangibles (2014 - 2019)
Relmada Therapeutics (RLMD) reported Amortizatization of Intangibles of $1.0 for Q2 2019, down 100.0% year-over-year from $527980.0 in Q2 2018, and down 100.0% quarter-over-quarter from $124647.0 in Q4 2018.
Relmada Therapeutics (RLMD) Amortizatization of Intangibles (2014 - 2019) Analysis & Trends
Relmada Therapeutics (RLMD) has 4 years of Amortizatization of Intangibles data on file, last reported at $1.0 in Q2 2019.
- Amortizatization of Intangibles for Q2 2019 came in at $1.0, down 100.0% year-over-year; the trailing twelve-month figure through Jun 2019 was $661168.0 (down 35.76% YoY), and the FY2019 annual result was $661168.0, down 35.76% from the prior year.
- Amortizatization of Intangibles declined to $1.0 in Q2 2019 per RLMD's latest filing, from $124647.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $536520.0 in Q3 2018 and troughed at $1.0 in Q2 2019.
- A 3-year average of $241478.7 and a median of $204962.0 in 2017 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2018 and 2019: Amortizatization of Intangibles jumped 18932.28% in 2018, then slumped 100.0% in 2019.
- A 3-year view of Amortizatization of Intangibles shows it stood at $204962.0 in 2017, then plunged by 39.19% to $124647.0 in 2018, then tumbled by 100.0% to $1.0 in 2019.
- Business Quant data shows RLMD's Amortizatization of Intangibles at $1.0 in Q2 2019, $124647.0 in Q4 2018, and $536520.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Relmada Therapeutics | 575.00 Mn | 575.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 1.00 |
| Jun 30, 2019 | 1.00 |
| Dec 31, 2018 | 124,647.00 |
| Dec 31, 2018 | 124,647.00 |
| Sep 30, 2018 | 536,520.00 |
| Sep 30, 2018 | 536,520.00 |
| Jun 30, 2018 | 527,980.00 |
| Jun 30, 2018 | 527,980.00 |
| Mar 31, 2018 | 293,422.00 |
| Mar 31, 2018 | 293,422.00 |
| Dec 31, 2017 | 204,962.00 |
| Dec 31, 2017 | 204,962.00 |
| Sep 30, 2017 | 2,819.00 |
| Sep 30, 2017 | 2,819.00 |
| Jun 30, 2014 | 327,776.00 |
| Jun 30, 2014 | 327,776.00 |
| Mar 31, 2014 | 172,818.00 |
| Mar 31, 2014 | 172,818.00 |